Synonyms: AMC-109 | LTX 109 | LTX-109 | Lytixar®
Compound class:
Synthetic organic
Comment: Voxvoganan is the clinical lead from a series of synthetic antimicrobial peptidomimetics (SAMPs) with Gram-positive and Gram-negative antibacterial activity [1-2].
|
|
References |
1. Haug BE, Stensen W, Kalaaji M, Rekdal Ø, Svendsen JS. (2008)
Synthetic antimicrobial peptidomimetics with therapeutic potential. J Med Chem, 51 (14): 4306-14. [PMID:18570363] |
2. Isaksson J, Brandsdal BO, Engqvist M, Flaten GE, Svendsen JS, Stensen W. (2011)
A synthetic antimicrobial peptidomimetic (LTX 109): stereochemical impact on membrane disruption. J Med Chem, 54 (16): 5786-95. [PMID:21732630] |
3. Nilsson AC, Janson H, Wold H, Fugelli A, Andersson K, Håkangård C, Olsson P, Olsen WM. (2015)
LTX-109 is a novel agent for nasal decolonization of methicillin-resistant and -sensitive Staphylococcus aureus. Antimicrob Agents Chemother, 59 (1): 145-51. [PMID:25331699] |